Day one


Section One: Upstream Development:Cell Line and Cell Culture Processing


Section Two: Downstream Development: Recovery & Purification Virus Safety and Viral Clearance

Day Two


Section Three: Biosimilar Development and Production Biomanufacturing, Facility Readiness and GMP Compliance


Section Four: Analytical Methods and Technologies Formulation Strategies and Quality Control

Summit Background

World BioProcess Leaders China summit provides you with practical tools, technologies and strategies to drive efficiencies in your process development and biomanufacturing activities so you can accelerate your biologics to commercialization. Benefit from multiple case studies and industry experts who will share strategies to save you time and money while reducing the development timeline from IND to market.


You will learn how to navigate the CMC studies and regulatory challenges of biological products developed in China and compare requirements from the CFDA and US FDA. You will also learn about new approaches for upstream and downstream development, biomanufacturing facility readiness, analytical and quality control for a wide-range of biotherapeutics including ADCs, bispecifics, next-generation mAbs and biosimilars.


No other conference in China provides a more comprehensive update of the technical, scientific and strategic innovations across all phases of bioprocess development.

Previous and current speakers
  • Audrey Jia
    M.D., Ph.D, Former FDA biological product CMC
  • Zhiwei Song
    Principal Scientist, Expression Engineering, B
    A*STAR, Singapore
  • Scott Wheelwright
    Complya Asia, China
  • Steven Lee
    DRL Biologics Singapore Operations Pte Ltd, Sing
  • Fi Alonso
    Senior Director, External Supply, BioTherapeut
    Sciences, Pfizer Biotech, United States
  • James Sayer
    Director, Global Product Quality
    Amgen, United States
  • Kim Wong
    Director, Facilities & cGMP Support, BioProces
    Sanofi Pasteur, Canada
  • John Rasko
    Immediate Past Chair, Advisory Committee on Bi
    Therapeutic Goods Administration (TGA)
  • Satoru Noguchi
    Vice President, Emerging Market Business Unit
    Takeda (China) Holdings
  • Johannes Salzbrunn
    Head of GMP Downstream / Fill & Finish,
    Boehringer Ingelheim Shanghai Pharmaceuticals, China
  • Yariv Hefez
    Vice President Business Development, Portfolio
    Merck, USA
  • Rene Hoet, Ph.D.
    Vice President Global Biologics, Antibody Lead
    Bayer Healthcare, Germany
  • Robert Friesen, Ph.D.
    Vice President and Global Head of Biologics Re
    Janssen R&D, LLC (Johnson & Johnson), USA
  • Robert Friesen, Ph.D.
    Vice President and Global Head of Biologics Re
    Janssen R&D, LLC (Johnson & Johnson), USA
  • Jean-Christophe Pointeau
    General Manager, Commercial Operations
    Sanofi China
  • Axel Schleyer
    VP Business Development & Key Account Manageme
    Boehringer Ingelheim Biopharmaceuticals (China) Ltd
  • WU Chengbin
    President of R&D, Chief Scientific Officer
    Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • Hung Fai Poon
    R&D Director, Cell Culture,
    Hisun Pharma, China
  • Lei Sun
    Vice President, Technology and Manufacture,
    AutekBio, China
  • Feng He
    Senior Director and Quality Head
    Genor BioPharma,
  • Changlin Dou
    Deputy General Manager, BoAn Biotechnology
    Company, A Subsidiary of Luye Pharma Group, China
  • Scott Liu
    Henlius Biopharmaceutical
  • Huijun Gao

    Shanghai FDA
  • Chris Chen
    Senior Vice President and Chief Technology Off
    Wuxi AppTec
  • Bai Xianhong
    President & General Manager
    Biotech Pharmaceutical
  • Amy Que
    Executive Director, Protein Analytical Science
    Wuxi AppTec, China
  • Hui, Hu
    Vice Director, CPGJ Research Institute
    Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • Cheng Zhang
    Chief Scientific Technology Officer,
    Gmax BioPharm, China
  • Qi Wei Wu
    Vice President, Head of Biologics
    Haixi Pharmaceuticals, China
  • Deepak Hedge
    Product Development Director (CMC), Platform
    GlaxoSmithKline, China
  • Jun Xiang
    Vice President of Biotechnology Institute of S
    Shanghai CP Guojian Pharmaceutical Co., Ltd
  • Xueming Qian
    Chairman and CEO
    MabSpace Biosciences, China
  • Wenzhi Tian
    Founder and President
    ImmuneOnco Biopharma, China
  • Zhe Ru Zhang
    Shanghai JMT-Bio Inc, China
  • Hongtao Lu
    Executive Vice President, Scientific Research
    Zai Laboratory, China
  • Fei Jiang
    Director, Business Development
    3SBio Inc, China
  • Jason Li
    Vice President
    Genor Biopharma, China
  • Qing Qiao Robin Tan
    Head of Analytical Science
    Shanghai CP Guojian Pharmaceutical, China
  • Yanshan Huang
    Zhejiang Doer Biologics, China
  • Joe Zhou
    Genor Biopharma & Vice President, Walvax Group, China
  • Claudia Lin
    Vice President of Quality and Compliance
    Innovent Biologics, China
  • Hang Zhou
    Director of Biologics
    Wuxi AppTec Biopharmaceuticals, China
  • Frederic Rohmer
    General Manager
    Lilly Suzhou Manufacturing, China
Who should attend?
More than 180 participants are expected to attend "The Annual World BioProess Leaders China Summit 2016", attracting the strong contingent throughout the Asia Pacific, USA and Europe. To breakdown, the participants will mainly come from:
By Attendees:
  • Chief X Officer
  • Senior Vice President
  • Vice President for Biologics
  • Vice President for Biosimilars
  • Vice President of R&D
  • Vice President of Manufacturing
  • Vice President of Facilities
  • Head of Cell Line Development
  • Head Process Development
  • R&D Director / Manager
  • Manufacturing Director / Manager
  • Chief Scientist/ Principal Scientist
  • Lab Head
  • International Partnering Director / Manager
  • Product Director / Manager
  • Marketing Director / Manager
  • Sales Director / Manager
  • Strategic Development Director /Manager
  • Business Development Manager
  • Sales & Marketing Manager
By Industry:
  • Cell Line Engineering
  • Cell Culture, Media and Upstream Processing
  • Recovery, Purification and Downstream Processing
  • Virus and Pathogen Safety
  • Formulation and Delivery
  • Analytical Development
  • Quality, QC and QA
  • CMC Regulatory
  • Biomanufacturing and Manufacturing Sciences
  • Technical Operations
  • Facility Readiness and GMP Compliance
  • Single Use and Disposables
  • Biologics and Biotherapeutics
  • Biosimilars, ADCs and Bispecifics
  • New Technologies
  • Bio Parks
Media outlets
  • 生物通ebiotrade
  • 生物探索
  • 生技网
  • pharmacy focus asia
  • pharma tech
  • 中国生物工程杂志
  • 仪器信息网介绍
  • 生命谷
  • Pharmavoice
  • GEN
  • antpedia
  • 丁香园
  • Pharma China
  • Asia Pacific Biotech News
  • GBI
  • pharmaphorum’s

For more information,pls contact us by 021-31602153 or Email to